1,3-dipropyl-8-cyclopentylxanthine has been researched along with Dyskinesia, Medication-Induced in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mango, D | 1 |
Bonito-Oliva, A | 1 |
Ledonne, A | 1 |
Cappellacci, L | 1 |
Petrelli, R | 1 |
Nisticò, R | 1 |
Berretta, N | 1 |
Fisone, G | 1 |
Mercuri, NB | 1 |
Varty, GB | 1 |
Hodgson, RA | 1 |
Pond, AJ | 1 |
Grzelak, ME | 1 |
Parker, EM | 1 |
Hunter, JC | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
Topics: Action Potentials; Age Factors; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Anim | 2014 |
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus | 2008 |